White Matter Damage in the Cholinergic System Contributes to Cognitive Impairment in Subcortical Vascular Cognitive Impairment, No Dementia

Cholinergic deficiency has been implicated in the pathogenesis of vascular cognitive impairment (VCI), but the extent of involvement and underlying mechanism remain unclear. In this study, targeting the early stage of VCI, we determined regional atrophy within the basal forebrain and deficiency in cholinergic pathways in 25 patients with vascular cognitive impairment no dementia (VCIND) compared to 24 healthy elderly subjects. By applying stereotaxic cytoarchitectonic maps of the nucleus basalis of Meynert (NbM), no significant atrophy was identified in VCIND. Using probabilistic tractography analysis, our study tracked the two major white matter tracks which map to cholinergic pathways. We identified significantly lower fractional anisotropy (FA) in VCIND. Mediation analysis demonstrated that FA in the tracked pathways could fully account for the executive dysfunction, and partly mediate the memory and global cognition impairment. Our study suggests that the fibers mapped to the cholinergic pathways, but not the NbM, are significantly impaired in VCIND. MRI-based in vivo tracking of cholinergic pathways together with NbM measurement may become a valuable in vivo marker for evaluating the cholinergic system in cognitive disorders.

[1]  M. Mesulam,et al.  Cholinergic denervation in a pure multi-infarct state , 2003, Neurology.

[2]  H. Vankova Mini Mental State , 2010 .

[3]  C. Geula,et al.  Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase , 1988, The Journal of comparative neurology.

[4]  Keith A. Johnson,et al.  The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials , 2014, Neuron.

[5]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[6]  Daniel Rueckert,et al.  Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data , 2006, NeuroImage.

[7]  H. Tohgi,et al.  Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia , 2005, Journal of Neural Transmission.

[8]  D. Streiner,et al.  Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients. , 2007, Archives of neurology.

[9]  H. Heinsen,et al.  Atrophy of the Cholinergic Basal Forebrain Over the Adult Age Range and in Early Stages of Alzheimer's Disease , 2012, Biological Psychiatry.

[10]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[11]  C. Beaulieu,et al.  The basis of anisotropic water diffusion in the nervous system – a technical review , 2002, NMR in biomedicine.

[12]  Seol-Heui Han,et al.  The Effect of Ischemic Cholinergic Damage on Cognition in Patients With Subcortical Vascular Cognitive Impairment , 2012, Journal of geriatric psychiatry and neurology.

[13]  M. Ihara,et al.  Loss of Cholinergic Pathways in Vascular Dementia of the Binswanger Type , 2005, Dementia and Geriatric Cognitive Disorders.

[14]  O Salonen,et al.  Cognitive profile of subcortical ischaemic vascular disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  S. Salloway,et al.  Efficacy and Tolerability of Donepezil in Vascular Dementia: Positive Results of a 24-Week, Multicenter, International, Randomized, Placebo-Controlled Clinical Trial , 2003, Stroke.

[16]  Stefan Klöppel,et al.  Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study. , 2014, Journal of Alzheimer's disease : JAD.

[17]  Serge Gauthier,et al.  Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial , 2002, The Lancet.

[18]  Sandra E Black,et al.  Strategic involvement of cholinergic pathways and executive dysfunction: Does location of white matter signal hyperintensities matter? , 2003, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[19]  G. Frisoni,et al.  Fractional anisotropy changes in Alzheimer's disease depend on the underlying fiber tract architecture: a multiparametric DTI study using joint independent component analysis. , 2014, Journal of Alzheimer's disease : JAD.

[20]  Harald Hampel,et al.  The cholinergic system in mild cognitive impairment and Alzheimer's disease: An in vivo MRI and DTI study , 2011, Human brain mapping.

[21]  R. Doody,et al.  Donepezil in vascular dementia , 2003, Neurology.

[22]  Won-Jin Moon,et al.  Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia. , 2013, Journal of Alzheimer's disease : JAD.

[23]  Suiping Wang,et al.  Separate Brain Circuits Support Integrative and Semantic Priming in the Human Language System. , 2015, Cerebral cortex.

[24]  M. Mesulam,et al.  Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. , 1998, Brain : a journal of neurology.

[25]  H. Hanyu,et al.  MR features of the substantia innominata and therapeutic implications in dementias , 2007, Neurobiology of Aging.

[26]  R. Kalaria,et al.  Cholinergic Neuronal Deficits in CADASIL , 2007, Stroke.

[27]  K. Blennow,et al.  Decreased Cerebrospinal Fluid Acetylcholinesterase in Patients with Subcortical Ischemic Vascular Dementia , 2003, Dementia and Geriatric Cognitive Disorders.

[28]  Timothy A. Salthouse,et al.  Speed Mediation of Adult Age Differences in Cognition , 2005 .

[29]  D. Salmon,et al.  The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education , 1990, Annals of neurology.

[30]  K. Jellinger,et al.  Post-mortem assessment in vascular dementia: advances and aspirations , 2016, BMC Medicine.

[31]  P. Scheltens,et al.  Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[32]  K. Nagata,et al.  [Alzheimer's disease and vascular dementia]. , 2014, Nihon rinsho. Japanese journal of clinical medicine.

[33]  Piero Antuono,et al.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors , 2008, The Lancet Neurology.

[34]  P. Scheltens,et al.  Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[35]  K. Amunts,et al.  Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease. , 2010, Cerebral cortex.

[36]  Richard J. Kryscio,et al.  White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults , 2014, Neurobiology of Aging.

[37]  Agnieszka Z. Burzynska,et al.  Diffusion tensor imaging of cerebral white matter integrity in cognitive aging. , 2012, Biochimica et biophysica acta.

[38]  M. Mesulam Cholinergic Aspects of Aging and Alzheimer's Disease , 2012, Biological Psychiatry.

[39]  H. Chui,et al.  Preservation of neurons of the nucleus basalis in subcortical ischemic vascular disease. , 2012, Archives of neurology.

[40]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[41]  H. Möller,et al.  Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. , 2005, Brain : a journal of neurology.

[42]  S. Jang,et al.  Neural pathway from nucleus basalis of Meynert passing through the cingulum in the human brain , 2010, Brain Research.

[43]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[44]  D. A. Kenny,et al.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.

[45]  P. Basser,et al.  A model for diffusion in white matter in the brain. , 2005, Biophysical journal.